Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Y Wu

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|August 17, 2023
Pain associated with intravascular instrumentation reduces orthostatic tolerance and predisposes to vasovagal reactions in healthy young adults without needle phobia: a randomised controlled studyBrooke C D Hockin, Vera-Ellen M Lucci, Ryan E Y Wu, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|August 1, 1997
High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasmaE Y Wu, J M Wilkinson, D G Naret, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Initial clinical trial and pharmacokinetics of Thymitaq (AG337) by 10-day continuous infusion in patients with advanced solid tumorsP J Creaven, L Pendyala, N J Meropol, et al.
Arthritis Research & Therapy|August 10, 2022
Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitisC King, R Patel, C Mendoza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusionP J O'Dwyer, P B Laub, D DeMaria, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumorsR T Koda, A A Garcia, D J Chatterjee, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|August 17, 2023
Pain associated with intravascular instrumentation reduces orthostatic tolerance and predisposes to vasovagal reactions in healthy young adults without needle phobia: a randomised controlled studyBrooke C D Hockin, Vera-Ellen M Lucci, Ryan E Y Wu, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|August 1, 1997
High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasmaE Y Wu, J M Wilkinson, D G Naret, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Initial clinical trial and pharmacokinetics of Thymitaq (AG337) by 10-day continuous infusion in patients with advanced solid tumorsP J Creaven, L Pendyala, N J Meropol, et al.
Arthritis Research & Therapy|August 10, 2022
Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitisC King, R Patel, C Mendoza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusionP J O'Dwyer, P B Laub, D DeMaria, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumorsR T Koda, A A Garcia, D J Chatterjee, et al.
Pageof 3